Literature DB >> 14310204

ORAL CONTRACEPTIVE HORMONES AND BLOOD COAGULABILITY.

J M THOMSON, L POLLER.   

Abstract

Keywords:  BLOOD COAGULATION; BLOOD COAGULATION TESTS; CONTRACEPTIVES, ORAL; ETHINYL ESTRADIOL; MEGESTROL; MESTRANOL; NORETHINDRONE; NORETHYNODREL; PHARMACOLOGY; THROMBOPHLEBITIS; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1965        PMID： 14310204      PMCID： PMC1845781          DOI： 10.1136/bmj.2.5456.270

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  CEREBROVASCULAR ACCIDENTS AND ORAL CONTRACEPTION.

Authors:  K J ZILKHA
Journal:  Br Med J       Date:  1964-10-31

2.  Effect of exercise on the level of antihaemophilic globulin in human blood.

Authors:  C R RIZZA
Journal:  J Physiol       Date:  1961-04       Impact factor: 5.182

3.  A brain extract as a substitute for platelet suspensions in the thromboplastin generation test.

Authors:  W N BELL; H G ALTON
Journal:  Nature       Date:  1954-11-06       Impact factor: 49.962

4.  [Factor VII in pregnancy at term, labor and puerperium].

Authors:  U CIULLA; G SANTONI
Journal:  Haematologica       Date:  1954       Impact factor: 9.941

5.  Variations in clotting time, relative viscosity, and other physiochemical properties of the blood accompanying physical and emotional stress in the normotensive and hypertensive subject.

Authors:  R A SCHNEIDER; V M ZANGARI
Journal:  Psychosom Med       Date:  1951 Sep-Oct       Impact factor: 4.312

6.  A heparin-retarded plasma clotting test.

Authors:  L POLLER
Journal:  Angiology       Date:  1954-02       Impact factor: 3.619

7.  [Factor VII; its role in coagulation; its clinical importance].

Authors:  F KOLLER; A LOELIGER; F DUCKERT
Journal:  Rev Hematol       Date:  1952
  7 in total
  15 in total

1.  Clothing factors during oral contraception: further report.

Authors:  L Poller; J M Thomson
Journal:  Br Med J       Date:  1966-07-02

2.  Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover study.

Authors:  L Poller; P K MacCallum; J M Thomson; W Kerns
Journal:  Br Heart J       Date:  1990-04

3.  Effects of manufacturing oral contraceptives on blood clotting.

Authors:  L Poller; J M Thomson; B W Otridge; K F Yee; S H Logan
Journal:  Br Med J       Date:  1979-06-30

4.  The effects of progestogens on blood clotting and platelet function.

Authors:  L Poller
Journal:  J Clin Pathol       Date:  1972-11       Impact factor: 3.411

5.  Effect of an antifertility preparation on a fibrinogen-fibrinolysin system in vitro.

Authors:  H A Moses; H M Frazier; R M Field
Journal:  J Natl Med Assoc       Date:  1969-09       Impact factor: 1.798

6.  Progesterone oral contraception and blood coagulation.

Authors:  L Poller; J M Thomson; A Tabiowo; C M Priest
Journal:  Br Med J       Date:  1969-03-01

7.  Coagulation studies in haemophilic patients taking oral contraceptives.

Authors:  A L Bloom; P Beck; J C Giddings; P M Sweetnam
Journal:  J Clin Pathol       Date:  1971-02       Impact factor: 3.411

8.  Reversible mesenteric vascular occlusion associated with oral contraceptives.

Authors:  B J Nothmann; S Chittinand; M M Schuster
Journal:  Am J Dig Dis       Date:  1973-05

9.  Oestrogen-progestogen oral contraception and blood clotting: a long-term follow-up.

Authors:  L Poller; J M Thomson; W Thomas
Journal:  Br Med J       Date:  1971-12-11

10.  Clinical evaluation of a new sequential oral contraceptive agent.

Authors:  L E Cowan
Journal:  Can Med Assoc J       Date:  1967-04-29       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.